SLC5A2 and diabetes mellitus: One author (ABV) searched PubMed and Google Scholar for “SGLT inhibitors and diabetes mellitus,” “SGLT inhibitors and heart,” “SGLT inhibitors and kidney,” and “SGLT inhibitors and cognitive impairment.” Several combinations including the terms, “humans,” “cats,” “veterinary,” “SGLT1,” “SGLT2,” “review,” “cardioprotection,” “renal protection,” and “neuroprotection” were used to identify relevant publications up to June 2024.